Skip to main content
. 2014 Mar 31;592(Pt 12):2575–2590. doi: 10.1113/jphysiol.2013.265835

Figure 8. Inhibition of cyclic nucleotide gated channels attenuates ADO dilation.

Figure 8

Dilation to ADO in the absence (white bar) or presence (black bar) of the cyclic nucleotide gated channel blocker l-cis-diltiazem. Arteriolar functionality and l-cis-diltiazem specificity is demonstrated by the ability to dilate in response to SNP in the presence of l-cis-diltiazem (striped bar). *Significantly different from ADO (P ≤ 0.05). Bars are mean of n = 6 responses, ± s.e.m. ADO, adenosine; SNP, sodium nitroprusside.